Literature DB >> 19643730

Slc26a9 is inhibited by the R-region of the cystic fibrosis transmembrane conductance regulator via the STAS domain.

Min-Hwang Chang1, Consuelo Plata, Aleksandra Sindic, Wasantha K Ranatunga, An-Ping Chen, Kambiz Zandi-Nejad, Kim W Chan, James Thompson, David B Mount, Michael F Romero.   

Abstract

SLC26 proteins function as anion exchangers, channels, and sensors. Previous cellular studies have shown that Slc26a3 and Slc26a6 interact with the R-region of the cystic fibrosis transmembrane conductance regulator (CFTR), (R)CFTR, via the Slc26-STAS (sulfate transporter anti-sigma) domain, resulting in mutual transport activation. We recently showed that Slc26a9 has both nCl(-)-HCO(3)(-) exchanger and Cl(-) channel function. In this study, we show that the purified STAS domain of Slc26a9 (a9STAS) binds purified (R)CFTR. When Slc26a9 and (R)CFTR fragments are co-expressed in Xenopus oocytes, both Slc26a9-mediated nCl(-)-HCO(3)(-) exchange and Cl(-) currents are almost fully inhibited. Deletion of the Slc26a9 STAS domain (a9-DeltaSTAS) virtually eliminated the Cl(-) currents with only a modest affect on nCl(-)-HCO(3)(-) exchange activity. Co-expression of a9-DeltaSTAS and the (R)CFTR fragment did not alter the residual a9-DeltaSTAS function. Replacing the Slc26a9 STAS domain with the Slc26a6 STAS domain (a6-a9-a6) does not change Slc26a9 function and is no longer inhibited by (R)CFTR. These data indicate that the Slc26a9-STAS domain, like other Slc26-STAS domains, binds CFTR in the R-region. However, unlike previously reported data, this binding interaction inhibits Slc26a9 ion transport activity. These results imply that Slc26-STAS domains may all interact with (R)CFTR but that the physiological outcome is specific to differing Slc26 proteins, allowing for dynamic and acute fine tuning of ion transport for various epithelia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19643730      PMCID: PMC2788881          DOI: 10.1074/jbc.M109.001669

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Cloning and characterization of a Na+-driven anion exchanger (NDAE1). A new bicarbonate transporter.

Authors:  M F Romero; D Henry; S Nelson; P J Harte; A K Dillon; C M Sciortino
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

2.  Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion.

Authors:  I E Royaux; S M Wall; L P Karniski; L A Everett; K Suzuki; M A Knepper; E D Green
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  Prestin is the motor protein of cochlear outer hair cells.

Authors:  J Zheng; W Shen; D Z He; K B Long; L D Madison; P Dallos
Journal:  Nature       Date:  2000-05-11       Impact factor: 49.962

4.  Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome.

Authors:  L A Everett; I A Belyantseva; K Noben-Trauth; R Cantos; A Chen; S I Thakkar; S L Hoogstraten-Miller; B Kachar; D K Wu; E D Green
Journal:  Hum Mol Genet       Date:  2001-01-15       Impact factor: 6.150

5.  Distinct outcomes of chloride diarrhoea in two siblings with identical genetic background of the disease: implications for early diagnosis and treatment.

Authors:  P Höglund; C Holmberg; P Sherman; J Kere
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

6.  Identification of seven novel mutations including the first two genomic rearrangements in SLC26A3 mutated in congenital chloride diarrhea.

Authors:  P Höglund; M Sormaala; S Haila; J Socha; U Rajaram; W Scheurlen; M Sinaasappel; H de Jonge; C Holmberg; H Yoshikawa; J Kere
Journal:  Hum Mutat       Date:  2001-09       Impact factor: 4.878

7.  Human hypertension caused by mutations in WNK kinases.

Authors:  F H Wilson; S Disse-Nicodème; K A Choate; K Ishikawa; C Nelson-Williams; I Desitter; M Gunel; D V Milford; G W Lipkin; J M Achard; M P Feely; B Dussol; Y Berland; R J Unwin; H Mayan; D B Simon; Z Farfel; X Jeunemaitre; R P Lifton
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

8.  Fructose-induced hypertension: essential role of chloride and fructose absorbing transporters PAT1 and Glut5.

Authors:  Anurag Kumar Singh; Hassane Amlal; Patrick J Haas; Ulrike Dringenberg; Stacey Fussell; Sharon L Barone; Regina Engelhardt; Jian Zuo; Ursula Seidler; Manoocher Soleimani
Journal:  Kidney Int       Date:  2008-05-21       Impact factor: 10.612

9.  Dynamic control of cystic fibrosis transmembrane conductance regulator Cl(-)/HCO3(-) selectivity by external Cl(-).

Authors:  Nikolay Shcheynikov; Kil Hwan Kim; Kyung-Mi Kim; Michael R Dorwart; Shigeru B H Ko; Hidemi Goto; Satoru Naruse; Philip J Thomas; Shmuel Muallem
Journal:  J Biol Chem       Date:  2004-03-09       Impact factor: 5.157

10.  Severed molecules functionally define the boundaries of the cystic fibrosis transmembrane conductance regulator's NH(2)-terminal nucleotide binding domain.

Authors:  K W Chan; L Csanády; D Seto-Young; A C Nairn; D C Gadsby
Journal:  J Gen Physiol       Date:  2000-08       Impact factor: 4.086

View more
  39 in total

Review 1.  STAS domain structure and function.

Authors:  Alok K Sharma; Alan C Rigby; Seth L Alper
Journal:  Cell Physiol Biochem       Date:  2011-11-16

Review 2.  Chansporter complexes in cell signaling.

Authors:  Geoffrey W Abbott
Journal:  FEBS Lett       Date:  2017-08-02       Impact factor: 4.124

3.  Functional regulation of the SLC26-family protein prestin by calcium/calmodulin.

Authors:  Jacob Pearson Keller; Kazuaki Homma; Chongwen Duan; Jing Zheng; Mary Ann Cheatham; Peter Dallos
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

Review 4.  Recent advances in developing therapeutics for cystic fibrosis.

Authors:  Lisa J Strug; Anne L Stephenson; Naim Panjwani; Ann Harris
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

Review 5.  Regulation of electroneutral NaCl absorption by the small intestine.

Authors:  Akira Kato; Michael F Romero
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

6.  Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.

Authors:  Melis A Aksit; Rhonda G Pace; Briana Vecchio-Pagán; Hua Ling; Johanna M Rommens; Pierre-Yves Boelle; Loic Guillot; Karen S Raraigh; Elizabeth Pugh; Peng Zhang; Lisa J Strug; Mitch L Drumm; Michael R Knowles; Garry R Cutting; Harriet Corvol; Scott M Blackman
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

7.  Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.

Authors:  Weili Li; David Soave; Melissa R Miller; Katherine Keenan; Fan Lin; Jiafen Gong; Theodore Chiang; Anne L Stephenson; Peter Durie; Johanna Rommens; Lei Sun; Lisa J Strug
Journal:  Hum Genet       Date:  2013-09-22       Impact factor: 4.132

8.  The anion transporter SLC26A9 localizes to tight junctions and is degraded by the proteasome when co-expressed with F508del-CFTR.

Authors:  Yukiko Sato; David Y Thomas; John W Hanrahan
Journal:  J Biol Chem       Date:  2019-10-23       Impact factor: 5.157

9.  Missense mutations in SLC26A8, encoding a sperm-specific activator of CFTR, are associated with human asthenozoospermia.

Authors:  Thassadite Dirami; Baptiste Rode; Mathilde Jollivet; Nathalie Da Silva; Denise Escalier; Natacha Gaitch; Caroline Norez; Pierre Tuffery; Jean-Philippe Wolf; Frédéric Becq; Pierre F Ray; Emmanuel Dulioust; Gérard Gacon; Thierry Bienvenu; Aminata Touré
Journal:  Am J Hum Genet       Date:  2013-04-11       Impact factor: 11.025

10.  Structural insights into the gating mechanism of human SLC26A9 mediated by its C-terminal sequence.

Authors:  Ximin Chi; Xueqin Jin; Yun Chen; Xiaoli Lu; Xinyu Tu; Xiaorong Li; Yuanyuan Zhang; Jianlin Lei; Jing Huang; Zhuo Huang; Qiang Zhou; Xiaojing Pan
Journal:  Cell Discov       Date:  2020-08-10       Impact factor: 10.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.